Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04408222|
Recruitment Status : Active, not recruiting
First Posted : May 29, 2020
Last Update Posted : May 29, 2020
|Condition or disease||Intervention/treatment|
|Oxygen Deficiency Coronavirus Infection||Other: Awake proning|
|Study Type :||Observational|
|Actual Enrollment :||29 participants|
|Official Title:||Awake Proning in Patients With COVID-19-Induced Acute Hypoxemic Respiratory Failure|
|Actual Study Start Date :||April 16, 2020|
|Estimated Primary Completion Date :||April 2021|
|Estimated Study Completion Date :||May 2021|
COVID-19 patients with hypoxemic respiratory failure with awake prone positioning, as tolerated, up to 24 hours daily.
Other: Awake proning
Prone positioning of awake, as tolerated, for up to 24 hours daily.
- Change in SpO2 [ Time Frame: Before proning and 1 hour after initiation of the prone position ]SpO2 was measured by peripheral pulse oximetry.
- Mean Risk Difference in Intubation Rates [ Time Frame: Duration of hospitalization or up to 1 month from admission ]The mean risk difference in intubation rates for patients with SpO2 ≥95% vs. <95% 1 hour after initiation of the prone position was assessed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04408222
|United States, New York|
|Columbia University Medical Center|
|New York, New York, United States, 10032|
|Principal Investigator:||Sanja Jelic, MD||Columbia University|